我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Kleiner-Perkins and Genentech: When Venture Capital Met Science

商品編號: 9-813-102
出版日期: 2012/10/27
作者姓名:
Hardymon, G. Felda;Nicholas, Tom
商品類別: Entrepreneurship
商品規格: 18p

再版日期: 2022/03/31
地域: United States
產業: Biotechnology industry;Business consulting services
個案年度: 1970 -  2000

 


商品敘述:

Genentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into viable therapeutic products with mass market appeal, something that most scientists agreed was at least a decade away. The founders, Herbert Boyer and Robert Swanson had limited financial resources, so they turned to Tom Perkins, the co-founder of Kleiner-Perkins, for venture funding. Genentech developed through an effective union between scientific and venture investment mindsets. In 1980 an IPO valued Genentech at $300 million. In 2009 it was fully acquired by the Swiss-based healthcare company, Roche, for $47 billion. Roche had held a majority stake in the company since 1990.


涵蓋領域:

Entrepreneurs and founders;Finance and investing;Going public;Innovation;Technology and analytics;Venture capital;Inventions


相關資料: